Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer

Clinical Cancer Research

Volumn 8, Issue 1, 2002, Pages 149-155

  Einspahr, Janine G ^a   Nelson, Mark A ^a   Saboda, Kathylynn ^a   Warneke, James ^a   Bowden, G Timothy ^a   Alberts, David S ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; ORNITHINE DECARBOXYLASE INHIBITOR; POLYAMINE; SPERMIDINE;

ACTINIC KERATOSIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOMA;

AGED; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOPSY; CELL DIVISION; EFLORNITHINE; ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KERATOSIS; MALE; MUTATION; ORNITHINE DECARBOXYLASE; PHOTOSENSITIVITY DISORDERS; PROLIFERATING CELL NUCLEAR ANTIGEN; RISK FACTORS; SKIN NEOPLASMS; SPERMIDINE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036156755     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Clinical and histologic trends of melanoma
2. Cancer statistics 2000
3. New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up
4. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer
5. Cancer precursors
6. Malignant transformation of solar keratoses to squamous cell carcinoma
7. Epidemiology of actinic keratoses and squamous cell carcinoma
8. Progress in cancer chemoprevention: Perspectives on agent selection and short-term clinical intervention trials
9. Control of ornithine decarboxylase activity in α-difluoromethylornithine-resistant L1210 cells by polyamines and synthetic analogues
10. Chemoprevention of human actinic kerotoses by topical 2-(difluoromethyl)-dl-ornithine
11. Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis
12. Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers
13. Effect of green tea on p53 mutation distribution in ultraviolet B radiation-induced mouse skin tumors
14. Cancer chemoprevention in the 21st century: Genetics, risk modeling, and molecular targets
15. Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression
16. Dose de-escalation chemoprevention trial of α-difluoromethylornithine in patients with colon polyps
17. α-difluoromethylornithine induction of apoptosis: A mechanism which reverses pre-established cell proliferation and cancer initiation in esophageal carcinogenesis in zinc-deficient rats
18. NF-κB activation and susceptibility to apoptosis after polyamine depletion in intestinal epithelial cells
19. Polyamine depletion stabilizes p53 resulting in inhibition of normal intestinal epithelial cell proliferation